FSH (Male)

Description

What is the Oestradiol (Male) Test?

The Oestradiol (Male) Test from BiomarkersLabs.com measures serum oestradiol (E2) in men using a high-sensitivity assay calibrated to the lower oestrogen concentrations found in the male reference range. Oestradiol in men is produced primarily by peripheral aromatisation of testosterone and androstenedione in adipose tissue, liver, muscle, and other peripheral tissues, with a small direct contribution from the testes. While oestrogen is conventionally associated with female physiology, oestradiol plays important and well-established physiological roles in men — including maintenance of bone density, regulation of libido, cardiovascular protection, and modulation of the hypothalamic-pituitary-gonadal axis through oestrogen receptor-mediated negative feedback on LH secretion.

The clinical importance of oestradiol measurement in men has increased substantially with the growth of testosterone replacement therapy, where aromatisation of exogenous testosterone to oestradiol is a common and clinically significant phenomenon. Elevated oestradiol in men on TRT — particularly injectable testosterone, which produces supraphysiological testosterone peaks that drive aromatisation — causes gynaecomastia, fluid retention, mood instability, and suppression of the HPG axis. Conversely, over-suppression of oestradiol with aromatase inhibitors produces bone loss, joint pain, cardiovascular risk, and impaired libido. Maintaining oestradiol within the optimal physiological male range during TRT requires accurate measurement with a high-sensitivity assay specifically validated for male concentrations — standard female-range immunoassays are insufficiently precise at male oestradiol concentrations. Results are CLIA-certified (USA) and IVDR-compliant (EU/UK), delivered to the practitioner portal within 1–3 business days.

What does the Oestradiol (Male) Test measure?

Oestradiol (E2 — male high-sensitivity assay) — the primary biologically active oestrogen in men, produced by peripheral aromatisation of testosterone. Elevated oestradiol in men suppresses the HPG axis, causes gynaecomastia, impairs libido despite adequate testosterone levels, and promotes fluid retention. Very low oestradiol in men — as may result from over-aggressive aromatase inhibitor use — is associated with bone loss, joint aches, cardiovascular risk, and paradoxically reduced libido. The optimal physiological male oestradiol range is generally considered to be approximately 70–200 pmol/L (20–55 pg/mL), though clinical context and symptom status always guide interpretation.

Clinical indications

TRT monitoring — aromatisation assessment — oestradiol measurement is an essential component of TRT monitoring in men using injectable, topical, or pellet testosterone preparations, where aromatisation to oestradiol is common and clinically significant.

Gynaecomastia investigation — oestradiol is a primary driver of gynaecomastia in men; measurement alongside testosterone, LH, and prolactin characterises the hormonal cause and guides treatment decisions.

Aromatase inhibitor therapy monitoring — men on aromatase inhibitors (e.g. anastrozole, letrozole) to control oestradiol elevation during TRT require regular oestradiol monitoring to ensure oestradiol is not over-suppressed below the physiological male range.

Male hypogonadism — oestradiol context — elevated oestradiol from peripheral aromatisation in obese men can suppress the HPG axis and contribute to functional hypogonadism; oestradiol measurement quantifies this suppressive oestrogen contribution.

Bone health in men on TRT or with hypogonadism — oestradiol is the primary regulator of bone resorption in men as well as women; measurement is important in men at risk of osteoporosis associated with hypogonadism or aromatase inhibitor use.

Male fertility — HPG axis context — elevated oestradiol in infertile men suppresses LH and FSH, impairing spermatogenesis; measurement guides the use of selective oestrogen receptor modulators (SERMs) such as clomiphene in male fertility treatment.

Sample type and collection

Blood (serum). No fasting required. Venepuncture at an approved collection site. A male-specific high-sensitivity oestradiol assay must be used — standard clinical oestradiol assays are calibrated for female concentrations and are insufficiently accurate at the lower oestradiol levels found in men, potentially producing unreliable results. Morning collection is preferred, though oestradiol does not show significant diurnal variation in men.

Turnaround time

1–3 business days from specimen receipt.

Availability

USA · EU · UK · Canada

Compliance

CLIA Certified · IVDR Compliant · CE Marked · HIPAA Compliant · GDPR Compliant · PIPEDA Compliant

How to order

Register free at BiomarkersLabs.com. Licensed practitioners only. Pay per test — no subscription required. Results are delivered directly and securely to your practitioner portal and are never released directly to patients.